Skip to main content
Premium Trial:

Request an Annual Quote

Applera Grants 266K Restricted Stock Units to Executive Officers

NEW YORK, Nov. 25 (GenomeWeb News) - 

The management resources committee of Applera's board of directors last week approved a grant of Applied Biosystems restricted stock units to several officers and employees of Applera and its subsidiaries, the companies said this week in a statement.

 

Each restricted stock unit gives recipients the right to one share of ABI common stock at the time the restricted unit vests, Applera said. Restricted units bestowed to executive officers typically vest in four increments, each amounting to 25 percent of the total value, occurring at the ends of fiscal years 2006, 2007, 2008, and 2009, the company added.

 

The grant follows Applera's Amended and Restated 1999 Stock Incentive Plan, and includes the following restricted stock transactions involving company officers: 88,800 shares granted to Tony White, Applera CEO; 43,200 shares granted to Catherine Burzik, senior vice president and president of ABI; 12,000 shares granted to Ugo DeBlasi, Applera vice president and controller; 19,200 shares granted to Dennis Gilbert, ABI CSO and vice president for research; 25,200 shares granted to Barbara Kerr, vice president of human resources at Applera; 15,600 shares granted to Sandeep Nayyar, ABI vice president of finance; 31,200 shares granted to William Sawch, Applera senior vice president and general counsel; 31,200 shares granted to Dennis Winger, senior vice president and CFO of Applera.

The Scan

Push Toward Approval

The Wall Street Journal reports the US Food and Drug Administration is under pressure to grant full approval to SARS-CoV-2 vaccines.

Deer Exposure

About 40 percent of deer in a handful of US states carry antibodies to SARS-CoV-2, according to Nature News.

Millions But Not Enough

NPR reports the US is set to send 110 million SARS-CoV-2 vaccine doses abroad, but that billions are needed.

PNAS Papers on CRISPR-Edited Cancer Models, Multiple Sclerosis Neuroinflammation, Parasitic Wasps

In PNAS this week: gene-editing approach for developing cancer models, role of extracellular proteins in multiple sclerosis, and more.